viernes, 6 de noviembre de 2020

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study - PubMed

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study - PubMed

No hay comentarios:

Publicar un comentario